Endometrial epithelial integrity and subepithelial reticular fibre expression in progestin contraceptive acceptors

Human Reproduction

Volumn 15, Issue , 2000, Pages 189-196

  Wonodirekso, Sugito ^a   Affandi, Biran ^b   Siregar, Budiningsih ^b   Barasila, Atikah C ^a   Damayanti, Lia ^a   Rogers, Peter A W ^c  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b MONASH MEDICAL CENTRE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Breakthrough bleeding; Collagen III; Endometrial epithelium; Norethisterone enanthate; Progestin only contraceptives

Indexed keywords

COLLAGEN TYPE 3; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; GESTAGEN; LEVONORGESTREL; NORETHISTERONE ENANTATE;

ADULT; BREAKTHROUGH BLEEDING; CELL SHAPE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ECCHYMOSIS; ENDOMETRIUM ATROPHY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PETECHIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL;

EID: 0033832368     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.suppl_3.189     Document Type: Article

References (28)

1. Management of irregular uterine bleeding and spotting associated with Norplant®
2. The effect of transdermal estradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users
3. Histological changes in the ovary and uterus of rat after injectable contraceptive therapy
4. The distribution of estrogen and progesterone receptors in the human endometrial basal and functional layer during the normal menstrual cycle
5. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle
6. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using levonorgestrel-releasing system
7. Connective tissue
8. Alteration in cytokeratin expression precedes histological changes in epithelia of vitamin A-deficient rats
9. Endometrial vasculature in Norplant users: Preliminary results from hysteroscopic study
10. Clinical trial of norethysterone-enanthate (Norigest®) injected every two months
11. Seven years clinical experience of the injectable contraceptive, norethysterone-enanthate
12. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days
13. Serum progesterone and northisterone levels following injection of northisterone-enanthate in different sites and doses
14. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle
15. Multi-adhesive matrix proteins and their cell surface receptors
16. Regulation and restricted expression of interstitial collagenase suggest pivotal role in the initiation of menstruation
17. Intermediate filaments
18. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant
19. Pattern of expression and organization of cytokeratin intermediate filaments
20. Endometrial vasculature in Norplant® users
21. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel
22. Matrix metalloproteinases in normal menstruation
23. IFAP 300 is common to desmosomes and hemidesmosomes and is possible linker of intermediate filaments to these junctions
24. Immunohistochemical detection of type I, III, and IV collagen in endometrial implants
25. Clinical evaluation of the therapeutic effectiveness of ethinyl estradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception
26. Estrogen treatment for increased bleeding in Norplant users. Preliminary results
27. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant
28. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate (NET-EN) injectable progestogen contraceptive users